CV Sciences (CVSI) Accounts Payables (2011 - 2026)
CV Sciences (CVSI) reported Accounts Payables of $1.1 million for Q1 2026, down 27.81% on a YoY basis from $1.5 million in Q1 2025, and up 3.45% sequentially from $1.0 million in Q4 2025.
CV Sciences (CVSI) Accounts Payables (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Accounts Payables data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 27.81% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 27.81% YoY), and the FY2025 full-year result was $1.0 million, down 45.77% from the prior year.
- Accounts Payables improved to $1.1 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.7 million in Q1 2022 to a low of $1.0 million in Q4 2025.
- A 5-year average of $2.0 million and a median of $2.2 million in 2022 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 282.82% in 2022 and slumped 45.77% in 2025, its largest moves.
- Tracing CVSI's Accounts Payables over 5 years: stood at $2.3 million in 2022, then advanced by 1.09% to $2.3 million in 2023, then fell by 16.63% to $1.9 million in 2024, then tumbled by 45.77% to $1.0 million in 2025, then gained by 3.45% to $1.1 million in 2026.
- Business Quant data shows CVSI's Accounts Payables at $1.1 million in Q1 2026, $1.0 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | 2.25 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 2.62 Mn |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 646,000.00 |